Journal of Clinical Endocrinology & Metabolism, Vol 67, 6-16, Copyright © 1988 by Endocrine Society

ARTICLES

Binding of thyroid hormones to human plasma lipoproteins

S Benvenga, RE Gregg and J Robbins
Clinical Endocrinology Branch, National Institute of Diabetes, Digestive and Kidney Diseases, Bethesda, Maryland 20892.

The binding of T4, T3, and rT3 to plasma lipoproteins was investigated in normal subjects and patients with abnormal lipoprotein metabolism. Gel filtration on Sepharose CL-6B demonstrated iodothyronine binding to all lipoprotein classes. In the total lipoprotein fraction (density less than 1.210 g/mL), high density lipoproteins (HDL) were the major binders, accounting for 92% of lipoprotein-bound T4, 99% of lipoprotein- bound T3, and 55% of lipoprotein-bound rT3. The estimated iodothyronine binding in normal plasma to HDL, low density lipoproteins (LDL), and very low density lipoproteins (VLDL) was 3%, 0.2%, and 0.03% for T4, 6%, 0.05%, and 0.02% for T3, and 0.1%, 0.1%, and 0.01% for rT3, respectively. These estimates may be low owing to possible dissociation during chromatography and the short incubation period used to avoid changes in lipoprotein structure. In VLDL and LDL deficiency (abetalipoproteinemia), HDL deficiency (Tangier disease), LDL excess (type IIa hyperlipoproteinemia), and VLDL excess (type III, IV, and V hyperlipoproteinemia), the distribution of iodothyronines reflected the lipoprotein abnormality. Variations resulting from altered distribution within HDL subclasses were also found. Binding was saturable, with approximate dissociation constants for VLDL, LDL, and HDL of 10(-5)-10(- 6) mol/L. We conclude that thyroid hormones bind specifically to apolipoproteins, although additional binding by solubilization in the lipid components of the lipoproteins may also occur.

This article has been cited by other articles:

				S. Benvenga and J. Robbins Thyroid Hormone Efflux from Monolayer Cultures of Human Fibroblasts and Hepatocytes. Effect of Lipoproteins and Other Thyroxine Transport Proteins Endocrinology, October 1, 1998; 139(10): 4311 - 4318. [Abstract] [Full Text] [PDF]

				S. Benvenga Effect of Thyroxine on Low Density Lipoprotein Oxidation Another Thyroid Hormone Nongenomic Effect J. Clin. Endocrinol. Metab., September 1, 1998; 83(9): 3377 - 3378. [Full Text]

				T. Diekman, P. N. M. Demacker, J. J. P. Kastelein, A. F. H. Stalenhoef, and W. M. Wiersinga Increased Oxidizability of Low-Density Lipoproteins in Hypothyroidism J. Clin. Endocrinol. Metab., May 1, 1998; 83(5): 1752 - 1755. [Abstract] [Full Text]

				V. Sundaram, A. N. Hanna, L. Koneru, H. A. I. Newman, and J. M. Falko Both Hypothyroidism and Hyperthyroidism Enhance Low Density Lipoprotein Oxidation J. Clin. Endocrinol. Metab., October 1, 1997; 82(10): 3421 - 3424. [Abstract] [Full Text] [PDF]